Cellular experiments further confirmed that GIT treatment led to a reduction in PI3K, p-PI3K, AKT, and p-AKT levels in LC cells, supporting the pivotal function of the PI3K-Akt axis in GIT-mediated LC treatment. This evidence concerns the gene PIK3CA and laryngotracheoesophageal cleft.